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Abstract
Ovarian cancer is a deadly disease with long latency.
To understand the consequences of loss of follicle-
stimulating hormone receptor (FSH-R) signaling and to
explore why the atrophic and anovulatory ovaries of
follitropin receptor knockout (FORKO) mice develop
different types of ovarian tumors, including serous
papillary epithelial adenoma later in life, we usedmRNA
expression profiling to gain a comprehensive view of
misregulated genes. Using real-time quantitative re-
verse transcription–polymerase chain reaction, pro-
tein analysis, and cellular localization, we show, for
the first time, in vivo evidence that, in the absence of
FSH-R signaling, claudin-3, claudin-4, and claudin-11
are selectively upregulated, whereas claudin-1 de-
creases in ovarian surface epithelium and tumors in
comparison to wild type. In vitro experiments using a
mouse ovarian surface epithelial cell line derived from
wild-type females reveal direct hormonal influence on
claudin proteins. Although recent studies suggest
that cell junction proteins are differentially expressed
in ovarian tumors in women, the etiology of such
changes remains unclear. Our results suggest an
altered hormonal environment resulting from FSH-R
loss as a cause of early changes in tight junction pro-
teins that predispose the ovary to late-onset tumors
that occur with aging. More importantly, this study
identifies claudin-11 overexpression in mouse ovarian
serous cystadenoma.
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Introduction
Ovarian cancer is a silent killer that is the most deadly of all
gynecologic cancers striking women in their postmeno-
pausal years [1], and the mechanisms that give rise to the
late onset of this disease remain poorly understood. It is
believed that themore frequent awomanovulates during her
reproductive life, the higher is her risk for epithelial ovarian
tumors in later years [2]. Although premenopausal women
develop more germ cell tumors with a lower incidence of
epithelial tumors [3], cancer of the latter cell type predominates
in postmenopausal women who suffer from ovarian cancer [4].
However, as not all postmenopausal women will develop ovar-
ian cancer, other factors, including genetic predisposition or
environment-related epigenetic influences, could increase
the risk for ovarian tumors. Cellular and biochemical bases
for differences in tumor types with aging, as well as initial pro-
cesses that cause late tumorigenesis, are unknown. Clearly, a
better understanding of these pathways will be helpful and
crucial in developing early markers for disease prediction or
detection. Although several cohort studies could not find an in-
creased risk of infertility treatment for ovarian cancer develop-
ment, data from a pooled analysis of case–control studies now
suggest that infertility itself poses a significant risk [5]. Thus,
the conundrum of ovulation risks and high circulating gonado-
tropins in menopause that propel and propagate epithelial
tumors remains an enigma [6].
As ovarian epithelial tumors are rare in rodents, investigators
have resorted to transgenic approaches directing viral antigens
to compartments that can model ovarian cancers in mice [7],
but these do not necessarily replicate hormonal imbalances
that could be present in women or a menopausal environ-
ment where disease incidence remains highest. We have
previously reported that follitropin receptor knockout (FORKO)
mice mimic menopausal conditions in women [8] in that they
exhibit hypergonadotropic hypogonadism, fail to ovulate, and
remain sterile but develop ovarian tumors with aging [9]. Our
recent microarray comparisons and other studies of mutant
ovaries revealed early histologic changes in the ovarian surface
epithelium (OSE) of null mutants from postnatal day 2 onward,
escalating up to 12 months [10]. Migration of cells expressing
cytokeratin, an epithelial cell marker, that began in 3- to 4-week-
old female mice intensified with age, suggesting potential
structural alterations within ovarian cells. By 12 months,
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most animals developed tumors that could be classified into
several categories, including granulosa cell tumors, Sertoli-
Leydig cell tumors [9], and serous papillary epithelial adeno-
mas (Figure 1) [10]. Identification of serous papillary epithelial
adenoma was confirmed by lack of staining with 3b-hydroxy
steroid dehydrogenase and inhibin-a. Such tumors were also
stained by Ep-CAM and histologically resembled serous
papillary adenoma found in human ovaries. Evidence of in-
filtration of epithelial cells or dedifferentiation within the ovary
with increasing age indicated that neither incessant (multiple)
ovulation nor the presence of follicle-stimulating hormone
receptor (FSH-R) on the OSE is required to induce the mi-
gration of epithelial cells in a mutant ovary.
Several recent studies describing altered expressions of
tight junction (TJ) proteins in epithelial ovarian tumors in
women hold such alterations accountable for epithelial cell
growth and survival [11–14]. As these studies are confined to
the use of late tumor tissues or established cells derived
therefrom, there is a critical gap in knowledge on the etiology
or chronology of changes in proteins of normal ovarian
surface epithelial cell junctions and their propensity to neo-
plastic transformations under altered conditions that could
arise as part of pathology or normal aging. Studying the
ovaries of FORKO mice at an age before the appearance of
pathology, we now show for the first time that hormonal
imbalances play an important role in inducing alterations in
four ovarian claudin familymember proteins that are known to
act as proto-oncogenes. We provide evidence for their ex-
clusive cellular localization in ovarian surface epithelial cells
of FORKO mutants and in serous papillary epithelial ade-
noma. Additional studies with cells also indicate a direct role
for hormones in epithelial cells. These observations might
provide the foundation for exploring mechanisms and signal-
ing pathways, as well as for testing novel options for reversal.
Materials and Methods
Animals and Tissue Collection
The studies described in this report were performed ac-
cording to accepted and approved guidelines of the institu-
tional animal care committee. FORKO mice were established
Figure 1. Evidence for the development of serous epithelial tumors in FORKO mice. Ovarian histopathology of WT and FORKO mice at 12 months of age. Normal
ovary at 12 months of age in wild-type mice containing antral follicles and corpora lutea (A and C). Appearance of serous tumors in FORKO mice at 12 months of
age (B and D). The appearance of serous tumors was characterized by a tall, columnar, ciliated epithelial cell lining and a clear serous fluid filling the cystic space.
Note that the remnant of the ovary is small, with few identifiable follicular structures compared with the tumor. (C) and (D) are high-power magnifications of (A) and
(B), respectively.
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as described [8] by breeding 129T2/SV EmsJ FSH-R+/
male and female mice aged 3 to 5 months. These breeding
pairs provided littermate +/+ and / females that would
allow direct comparison. All mice were fed standard labora-
tory chow (5001/Harlan Teklad S-2335 diet, 1:1 mixture;
Harlan Teklad, Madison, WI) and were maintained under a
12L:12D regimen.
Affymetrix Gene Chip mRNA Expression Analyses
and Quantitative Polymerase Chain Reaction (Q-PCR)
We first hypothesized that direct microarray analysis
comparing ovaries from normal and mutant mice would
provide clues to global changes in gene alterations. For
microarray analysis, ovaries from age-matched 8-month-old
wild-type or FORKO mice (n = 3) were used. This age was
chosen because we wanted to examine the latency of
ovarian gene changes before overt tumors developed. The
Affymetrix 39K GeneChip Mouse Genome 430 2.0 Array
(Affymetrix, Santa Clara, CA) with 45,000 probe sets ana-
lyzes > 39,000 transcripts and variants of mouse genes.
GeneChip arrays were used according to Affymetrix pro-
tocols (Affymetrix). Comparison of data between wild-type
and FORKO ovaries was performed with GeneSpring 7.2
software (Silicon Genetics, Redwood City, CA) with default
normalization scheme.
For RNA extraction in Q-PCR, both ovaries from a different
set of animals (n = 5 for wild type and FORKO) were carefully
dissected and pooled. Wild-type mice were selected at ran-
dom without regard to the stage of estrous cycles, and this
characteristic does not apply to mutants as they do not cycle.
Q-PCR was performed using QuantiTect Probe Q-PCR Kit
(Qiagen, Mississauga, Ontario, Canada). Expressions of dif-
ferent transcripts were determined in relation to b-actin with
real-time PCR on Mx4000 (Stratagene, La Jolla, CA).
Ovarian Gene Expression in Normal Mice Treated
with Gonadotropin
To investigate if claudin gene products relevant to this
report and identified as differentially regulated by microarray
were the result of lack of FSH-R signaling, we injected
sexually immature 24-day-old wild-type mice and age-
matched FORKO mice with 5 IU of equine chorionic gonad-
otropin (eCG; a FSH surrogate hormone) and performed
Q-PCR analyses on ovarian RNA 24 hours posttreatment.
This treatment synchronizes immature follicles in wild type
by accelerating their development and by allowing rapid
analysis of hormonal effects. Age-matched untreated wild-
type and FORKOmice were used as controls (n = 5). Ovaries
were collected for RNA processing as above.
Sodium Dodecyl Sulfate–Polyacrylamide Gel
Electrophoresis (SDS-PAGE)–Western Blot Analysis
Whole ovaries from 8-month age-matched wild-type and
FORKO mice (n = 6) were used for protein isolation using a
standard lysis buffer containing protease inhibitors. Forty
micrograms of total protein was separated by SDS-PAGE.
After transfer, membranes were incubated overnight at 4jC
with the following primary antibodies: rabbit polyclonal anti-
body to claudin-1 (1:200; Zymed Laboratories, San Fran-
cisco, CA), claudin-3, claudin-4, and claudin-11 (1:200; a kind
gift from Dr. M. Furuse, Kyoto University, Kyoto, Japan).
Alkaline phosphatase–conjugated secondary antibodies
(1:10,000) diluted in blocking reagent were incubated with
membranes for 1 hour at room temperature. Immunoreactive
protein was visualized using chemiluminescence (Bio/Can
Scientific, Inc., Mississauga, Ontario, Canada), and band
densities were computed for comparison.
Immunofluorescence
Fresh frozen ovarian sections of 8-month-old mice (wild
type and FORKO) and serous papillary epithelial adenoma
samples from 1-year-old null mice were cryosectioned and
fixed in acetone for 15 minutes, air dried in room tempera-
ture, and frozen at 20jC until analysis. Primary antibodies
were used at 1:100 concentrations for claudin-1, claudin-3,
claudin-4, and claudin-11, and fluorescein isothiocyanate–
conjugated secondary antibodies (Sigma, Ontario, Canada)
were used at the recommended concentration of 1:120. To
quantify fluorescence intensities, the histology of samples
was evaluated with a cursor drawing delineating the region of
interest, which is called mask. That region/mask was then
applied to the corresponding fluorescent image, and area
fluorescence intensity was measured. Using constant set-
tings, 100 epithelial cells selected at random from five differ-
ent wild-type and FORKO mice were electronically scanned
with 512 512 pixels. The images were recorded with 8 bits/
pixel, resulting in 255 intensity levels. Using the LSM soft-
ware (LSM 510, ApoChromat x40; Zeiss, Jena, Germany),
the intensity of immunofluorescence above the threshold
was measured (mean intensity per pixel).
Culture of ID-8 Ovarian Epithelial Cells
In the absence of an established mouse ovarian surface
epithelial cell line (MOSEC) from FORKO mutants, we
resorted to an epithelial cell line from normal mice (ID-8) that
was kindly provided by Drs. Paul F. Terranova and Katherine
Roby (University of Kansas Medical Center, Kansas City,
KS) to investigate the impact of hormones. These cells, which
were obtained after serial passage and have the potential to
induce peritoneal tumors in recipient mice, were grown in
plastic culture ware, as described previously [15]. Cells
(5000–100,000 per well) grown for 2 days in six-well plates
were starved of serum and growth factors overnight before
treatment with different hormones, namely, highly purified
hFSH (1–200 ng/ml) and hLH (1–200 ng/ml) (both from our
laboratory), 17b estradiol (106 –109M), testosterone
(106–109M), and progesterone (106–109 M) (all from
Sigma, St. Louis, MO) for 24 hours. Protein hormones were
dissolved in saline, and steroid hormone stock solutions were
prepared in ethanol and diluted with culture medium. Cells
were lysed following treatment, and claudin protein expres-
sion was quantified by Western blot analysis using the
respective antibodies. Actin determined for each well and in
the same blot was used for normalizing and comparing
untreated wells.
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Steroid Hormone Levels and Statistical Analysis
Plasma levels of steroid hormones at two different ages
(pretumor, 3 months; posttumor, 12 months) were measured
using specific radioimmunoassays as described earlier [16].
Statistical differences were assessed by Student’s t test
and considered significant at P < .05. Data in various figures
are presented as mean ± SEM.
Results
Affymetrix Profiling of mRNA Expression in FORKO Ovary
Aging FORKO mice exhibit varied ovarian pathologies,
with tumors developing in the majority of females by 1 year
[9], including serous papillary epithelial adenoma in 30% of
aging mice (Figure 1). The epithelial nature of these tumors
was confirmed by histologic examinations and expression of
appropriate cell markers [10]; the description of their nature
will be reported elsewhere (Chen et al., manuscript in prep-
aration). These observations prompted the current investiga-
tion to first determine global gene changes using Affymetrix
microarrays. We hypothesized that a global analysis of the
ovary at an age before tumor development would indicate
evidence of gene expression changes that predispose the
ovary to autocrine and paracrine interactions among dif-
ferent and altered compartments within the ovary. Additional
details of these analytical studies, including the classifica-
tion of altered gene families, will be reported elsewhere
(Aravindakshan et al., manuscript in preparation). The com-
plete data are available through the Gene Expression Om-
nibus (GEO) data repository (http://www.ncbi.nlm.nih.gov/
geo/; GEO accession number GSE4323). As this initial
analysis provided a number of candidates, including those
that could be novel to the ovary, we chose two sets of genes
(platelet-derived growth factors [PDGFs] and their receptors,
and the claudin family) for further exploration. Among other
considerations was their relationship with the OSE. Our
findings on alterations in PDGF ligands and receptors in
normal ovaries and mutant ovaries, including expressions
in surface epithelial cells, have been recently reported [17].
Genes of the claudin family discussed here, consisting of
23 members participating in TJs and involved in epithelial
cell–cell interactions, have attracted increasing attention to
ovarian cancers [18].
Genes Encoding TJs Are Altered in the Absence
of FSH-R Signaling
Among numerous differentially expressed genes in
mutants are claudin family genes that have not been well
characterized. Four members of this large family of proteins
proposed to be involved in TJs are expressed in the mouse
ovary. Microarray data showed consistent high expression of
claudin-11, followed by claudin-3 and claudin-4, and down-
regulation of claudin-1 gene in mutant ovaries. Q-PCR anal-
ysis confirmed that although claudin-1 decreased 2.6-fold
(Figure 2A), claudin-3, claudin-4, and claudin-11 increased
2.9-fold (Figure 2B), 2.4-fold (Figure 2C), and 10.2-fold
(Figure 2D), respectively, in 8-month-old FORKO ovaries
when compared with age-matched wild-typemice. To explore
how early these changes might begin following FSH-R de-
letion, we again compared ovarian claudin gene expression
in age-matched 24-day-old wild-type and FORKO mice by
Q-PCR. In young FORKO mice, claudin-1, claudin-3, and
claudin-11were altered as early as 24 days, whereas claudin-
4 did not change (data not shown). This strongly suggests
that claudin-1, claudin-3, and claudin-11 gene changes are
among the very early events of impending cellular alterations,
whereas claudin-4 might be considered as a marker of late
events. The importance of these gene changes to consider-
ations of ovarian epithelial cells will become evident in the
following sections. The relevance of these sequential ob-
servations that occur in the absence of FSH-R signaling is
important to note because delineation of such a chronology of
events is possible only in defined models, age comparisons
are impractical in women, and most expression studies are
performed in late-stage ovarian cancers.
Comparison of Ovarian Gene Expression in Mice Treated
with eCG
To test the hypothesis that changes in claudins in FORKO
ovaries are induced by lack of FSH signaling, we performed a
corollary experiment in which 24-day-old wild-type mice were
stimulated for 24 hours by eCG, an FSH-R agonist that
induces ovarian stimulation regardless of endogenous FSH.
FORKOmice of the sameagewere also treated as part of this
experiment for comparison. In wild-type females, claudin-1
mRNA was not altered, but expression of claudin-3 and
claudin-4 showed a decreasing trend following eCG treat-
ment (Figure 2, A–C). This treatment in wild-type mice also
significantly downregulated ovarian claudin-11 mRNA levels
(Figure 2D) and was consistent with the opposite effect seen
in FSH-R mutant ovaries. No change in claudinmRNA levels
was seen in FORKO mice treated with eCG, as they did not
respond to the deletion of FSH-R. As FSH signaling in normal
ovaries initiates a number of changes, including increase in
hormonal steroids, this suggests that altered hormones,
such as increased luteinizing hormone (LH) and androgen
or decreased estrogen and progesterone levels in FORKO
mice [16] (Figure 3, A and B), might play a role either indi-
vidually or synergistically to alter the expression of claudin
members. At present, virtually nothing is known on the impact
of steroid hormones in the regulation of claudin genes in the
ovary or in tumors (in animals or humans).
Ovarian Protein Expression Patterns in Mutants
To determine if transcriptional changes noted by altered
mRNA inmutant ovaries are also reflected at the translational
level, we quantified protein expression using Western blot
analysis. Our immunoblot results using specific antibodies
demonstrated that the amount of claudin-3, claudin-4, and
claudin-11 proteins was significantly increased in mutants at
8 months, whereas claudin-1 was drastically reduced or un-
detectable in most experiments (Figure 4, A–D). In addition
to revealing claudin-11 protein expression in themouse ovary
for the first time, the results also show that, among the four
claudin proteins compared between wild-type and mutant
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mice, claudin-11 expression showed the highest change (a
250% increase). This trend is consistent with the changes in
mRNA noted above. As change in ovarian claudin-11 gene/
protein wasmost predominant, we used it as a representative
of this family, focusing attention on its ontogeny in mutants
and wild-type mice. Western blot analysis carried out in age-
matched, wild-type, and FORKO mice at 24 days, 3 months,
6 months, and 12 months revealed a significant and sus-
tained increase in claudin-11 in mutants when compared to
that in wild-type mice (Figure 4E ). Claudin-11 protein levels
in wild-type mice remained constant. These results confirm
the above findings (based on gene expression and mRNA
levels) that selected claudins are altered in the ovaries of
FSH-R knockout mice. Cellular localization within the ovary,
as noted below, corroborates these observations and pro-
vides further evidence for selective expression and changes
in surface epithelial cells of mutants.
Immunofluorescence—Localization and Cellular Changes
To discount the possibility that different components of the
ovary might have contributed to differences seen in total
protein expression, we used comparative imaging and quan-
titation with confocal imaging systems. Using constant set-
tings, 100 epithelial cells selected at random from different
wild-type ovaries, FORKO ovaries, and tumor samples were
scanned for immunofluorescence (Figure 5), confirming the
above findings of Western blot analysis. Compared with +/+
animals, FORKO mice exhibit epithelial proliferation with
Figure 2. Quantitative analysis of claudin expression. Q-PCR was performed for each of the indicated claudins (A, claudin-1; B, claudin-3; C, claudin-4; D, claudin-
11) to confirm microarray results. mRNA expression is normalized to wild-type controls. To identify potential gonadotropin-responsive gene products, ovaries were
collected from sexually immature 24-day-old wild-type and FORKO females 24 hours after administering 5 IU of eCG, an FSH-R agonist. This treatment is
designed to activate FSH-responsive ovarian cells. Fold change values of eCG-treated +/+ mice are compared with vehicle-treated wild-type mice. WT, wild-type
vehicle-treated; FORKO, follitropin receptor knockout with vehicle; WT + eCG, wild-type mice administered eCG; FORKO + eCG, FORKO mice administered eCG.
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stratification, as seen in more than one layer of epithelial cells
by 8 months of age and in epithelial tumors developing
by 12 months of age (Figure 5). It is notable that the
TJ-associated proteins claudin-1, claudin-3, claudin-4, and
claudin-11 were distributed exclusively along epithelial cell
borders in +/+ mice (Figure 5, A–D). Their exclusive locali-
zation to ovarian epithelial cells, but not to either granulosa
cells or thecal cells, which are the classic dominant targets
of gonadotropins in the ovary, suggests a potential role in
maintaining cell integrity and barriers to epithelial cell mi-
gration under normal circumstances. In FORKO mice and
epithelial adenomas, staining was increased both in the
cytoplasm and along epithelial cell borders (Figure 5, E–L).
This first report of claudin-11 expression, a suggested proto-
oncogene [19], on the surface of mouse ovarian epithelial
cells (Figure 5D) and its increase in the absence of FSH-R
signaling (Figure 5, H and L) signify important cellular and
structural changes in the epithelium long before tumor prop-
agation occurs. In negative controls, no staining was seen.
Its aberrant cellular localization, in part, could also be signifi-
cant in altering cell–cell interactions and signaling. Other
tumor types that also appear in FORKO ovaries [9] were not
stained by antibodies to claudins (data not shown), indicating
that upregulation of these proteins as found in this study is
specific to the OSE type of tumors. Quantitative immuno-
fluorescence showed that, in FORKO ovarian samples,
claudin-3, claudin-4, and claudin-11 content was significantly
increased (P < .05) compared to ovarian epithelial cells in +/+
mice. However, the greatest increase was again seen in
claudin-11 protein expression. Interestingly, faint or very
little staining was observed for claudin-1, confirming data in
Figures 3 and 4. These data reinforce the idea that selected
claudin proteins participating in cell–cell interactions and
functioning as potential oncoproteins are differentially ex-
pressed in epithelial cells of FORKO ovary.
Hormonal Regulation of Adhering and TJ Proteins
in Cultured Epithelial Cells
Hormonal imbalances that are of significance to diverse
pathology occur early in life in FORKO mutants, as depicted
by circulating levels (Figure 3). Of particular interest to this
report are aberrations shown as testosterone/estrogen ratio
and decreased progesterone that occurs early and is sus-
tained with aging. As powerful hormonal transcriptional reg-
ulators, it is highly likely that these hormonal changes could
alter nuclear receptor interaction in cells. Although epithelial
cells isolated from FORKO mice at different ages would
constitute ideal systems for comparison with similar cells
from normal mice and for identifying aberrations and mech-
anisms, such cells are not yet currently available for our
study. As an alternative to this and to determine if compo-
nents contributing to hormonal imbalances in FORKO mice
could alter TJ proteins in the ovarian epithelium, we treated
an available mouse OSE cell line (ID-8) individually with five
hormones (FSH, LH, 17b estradiol, testosterone, and pro-
gesterone) for 24 hours. As indicated in the Materials and
Methods section, this cell line was established by serial
passage ofOSE derived from normalmice [15]. This question
becomes relevant because, in addition to high FSH and LH
[16], FORKO mice have sex steroid imbalances (Figure 3, A
and B), indicating androgen dominance and progesterone
deficit. We anticipated that such a study would provide
information relative to possible direct influences, if any, on
these types of cells. For brevity and clarity, results chosen
from the effects of two concentrations are summarized in
Figure 6. Treatment with FSH induced a significant decrease
in claudin-11. Although LH increased claudin-3, testosterone
increased claudin-3, claudin-4, and claudin-11 levels. There
was no effect on the low expression of claudin-1 by any of
the hormones tested in this cell line. The effect of androgen
on this cell line derived from the wild-type mouse epithelium
is particularly noteworthy as it is considered a risk factor for
ovarian tumors in women [20]. In support of this, we have
found that, among the hormones tested, only androgen
induced the maximal migration in ID-8 cells in culture (data
not shown). Estradiol showed a trend in increasing claudin-4
levels. Interestingly, progesterone did not affect any of the
proteins examined, suggesting that the apparent beneficial
effects of progesterone in suppressing ovarian tumors in
women [20,21] could be mediated by other pathway(s) or
Figure 3. Circulating sex steroid hormones and aging in female mice. (A) Plasma levels of steroid hormones were measured by specific radioimmunoassays at
3 and 12 months of age. Testosterone (n = 11–15 mice) and estradiol (n = 12) ratios are shown depicting androgen dominance in FORKOs. (B) Plasma levels of
progesterone (ng/ml) measured at 3 and 12 months (n = 8). Asterisks indicate significant differences from wild-type mice (P < .05).
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by interactions with other compartments in the intact ovary.
To our knowledge, this is the first study to show that different
hormones produced by the ovary and known to participate in
paracrine and intracrine actions can also directly and acutely
alter normal mouse ovarian epithelial cell junction proteins
and also occur exclusively in tumors of this cell type.
Discussion
Gonadotropins as important regulators of ovarian function
act by binding to specific receptors in target cells. Our recent
studies of FSH-R mutant ovaries revealed early histologic
changes in the OSE of null mutants from postnatal day 2
onward and escalating up to 12 months [10]. By 12 months,
Figure 4. Evidence for quantitative alterations in proteins associated with maintaining cell polarity in the ovary. A representative Western blot image of (A) claudin-
1, (B) claudin-3, (C) claudin-4, and (D) claudin-11 in 8-month-old ovaries of wild-type and FORKO mice (before tumors appear) is shown. (E) To further understand
the ontogeny of claudin-11 expression, claudin-11 expression was compared in age-matched, wild-type, and FORKO mice at 24 days, 3 months, 6 months, and
12 months. A representative image is shown here. Lanes 1, 3, 5, and 7 are protein extracts from wild-type mice. Lanes 2, 4, 6, and 8 are protein extracts from
FORKO mice. Protein levels were determined by densitometry and corrected for protein loading using -actin levels. Data are expressed as the percentage of wild-
type expression from three different experiments. Asterisks indicate significant differences from wild-type mice (P < .05).
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most animals develop tumors that can be classified into
several categories, including granulosa cell tumor, Sertoli-
Leydig cell tumor [9], and serous papillary epithelial adenoma
[10]. In support of this, studies from another laboratory, using
an independently derived FSH-R knockout or its ligand
(FSH) knockout (FSHbKO), resulted in the development of
serous ovarian adenomas in aging mice [22]. Because FSH
action is absent in FORKO females due to lack of FSH-R,
chronic exposure to high concentrations of LH and androgen
would appear to be the primary cause of the observed
pathology. In transgenic mice overexpressing LH transgene
[23], increased plasma LH concentrations have been impli-
cated in the initiation of subsequent ovarian pathology, but
no information on the role or alteration of TJ proteins in this
model is available.
Most epithelial cells are characterized by the ability to form
TJs. TJs, together with adherens junctions, form the apical
junctional complex in epithelial cells. Adherens junctions are
responsible for mechanical adhesion between adjacent cells,
whereas TJs are essential for controlling paracellular ion flux
and, therefore, for maintaining tissue homeostasis [24]. TJs
also play a crucial role in the maintenance of cell polarity.
Finally, because of the ability of TJ proteins to recruit signal-
ing proteins [25], TJs have also been hypothesized to be in-
volved in the regulation of proliferation, differentiation, and
other cellular functions.
As our microarray studies indicated changes in these
genes, we hypothesized links to ovarian pathology. We have
investigated the expression and localization of the TJ proteins
claudin-1, claudin-3, claudin-4, and claudin-11 in normal and
Figure 5. Cellular localization of TJ proteins in normal and tumor-prone mouse ovaries. Immunofluorescence analysis of claudin-1, claudin-3, claudin-4, and
claudin-11 staining in 8-month-old ovaries of different wild-type (A–D), FORKO (E–H), and serous papillary epithelial adenoma (I –L) samples. In the ovaries, the
predominant source of claudin expression is the epithelial cell population (arrows). Data are expressed as the percentage of wild-type expression. Asterisks
indicate significant differences from wild-type mice (P < .05). Representative sections from different animals are shown. Nuclear staining revealed by propidium
iodide is shown in red. Bars = 10 m.
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FORKO mouse ovaries. Recently, it has become apparent
that claudin gene expression is frequently altered in several
human cancers. However, the exact pattern of claudin ex-
pression in different tumors is unknown, as only a limited
number of claudin genes have been investigated in a few
tumors. In fact, studies published thus far report an over-
expression of claudin-3 and claudin-4 in late ovarian cancers
[11–14]. In this study, we found that although there were
significant increases in claudin-3 and claudin-4, the major
increase was in claudin-11 expression. This might be due to
differences in species or in the nature of the tumors studied.
Rangel et al. [13] reported that, in the human ovary, claudin-3
and claudin-4 mRNA are expressed at low levels in the
normal ovary, but are highly upregulated in epithelial ovarian
cancers of all subtypes. Also by immunohistochemical anal-
yses, it was confirmed that although a high level of expression
of claudin-3 and claudin-4 occurs in the majority of ovarian
carcinomas, ovarian cystadenoma did not frequently over-
express these proteins. In our mutant ovaries, most of the
epithelial tumors are of the cystadenoma type. This suggests
that overexpression of the TJ proteins depends on the
histologic type of cellular alterations. In further support of
these data, a review of the large publicly available SAGE
database [26], which is used to ascertain the gene expression
of claudin-11 in both normal and neoplastic human tissues,
has revealed that claudin-11 was specifically overexpressed
in ovarian cystadenoma (Table 1).
It is striking that the increase in claudin-3 and claudin-11
occurred long before tumors became apparent in our mutant
ovaries. This would suggest that changes in claudin might
trigger the increased epithelial cell migration that we see in
mutant ovaries when compared to wild-type ovaries. This
would appear to be consistent with increased claudin-3 and
claudin-4 expression contributing to increased ovarian sur-
face epithelial cell migration and survival [27]. Interestingly,
claudin-11 has also been shown to modulate the proliferation
and migration of oligodendrocytes [19]. Thus, future studies
will take this into consideration when assessing the signifi-
cance of increased claudin-11 expression in mutant ovaries
and in the generation of serous papillary adenomas.
Previously, claudin-1 has been shown to be present in
human ovarian surface epithelial cells and to be localized to
cell borders. Claudins were shown to form functional TJs [28].
Decreases in claudin-1 expression in breast cancer [29,30],
as well as in colon cancer [31], are suggestive of a possible
relationship with either tumorigenesis or propagation. Simi-
larly, the decrease in claudin-1 that we have observed in
FORKO ovaries and, more particularly, in OSE, as well as in
tumors attributable to this cell type in mutants (Figures 2 and
5), also indicates a close relationship with these two pro-
cesses. It is believed that the exact combination of claudin
Figure 6. Potential candidates (mechanisms) for altering adhering and TJ proteins in mouse ovarian epithelial cells. The ID-8 epithelial cell line from normal mice
(MOSEC) was starved of all serum and growth factors overnight before treatment with different concentrations of hormones, namely, highly purified hFSH (10 and
200 ng/ml) and hLH (10 and 200 ng/ml), 17 estradiol (106 and 109 M), testosterone (106 and 109 M), and progesterone (106 and 109 M) for 24 hours.
Treatment of ID-8 cells with 200 ng/ml FSH induced a significant decrease in claudin-11 (P < .05). Although LH increased claudin-3, testosterone increased claudin-3,
claudin-4, and claudin-11 levels. Data are expressed as the percentage of vehicle-treated control cells. Asterisks indicate significant differences (P < .05).
Table 1. SAGE Analysis of Claudin-11 Gene Expression in Normal and
Neoplastic Ovarian SAGE Libraries.
Library GAPDH Claudin-11 Normalized
to GAPDH
Ovary_adenocarcinoma_B_OVT-6 738 4 0.54
Ovary_adenocarcinoma_B_OVT-7 399 3 0.75
Ovary_adenocarcinoma_B_OVT-8 356 6 1.69
Ovary_carcinoma_CL_A2780 701 0 0
Ovary_carcinoma_CL_ES2-1 596 0 0
Ovary_cystadenoma_CL_ML10-10 805 83 10.31
Ovary_normal_CL_IOSE29EC-11 1378 21 1.52
Ovary_normal_CS_HOSE_4 1286 12 0.93
These data are derived from public databases. GAPDH levels are used as
controls. Note that claudin-11 expression is higher in an ovarian cystadenoma
library.
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proteins within a given tissue can determine the selectivity
and strength of TJs [32]. Therefore, in such cases, compro-
mising TJ integrity due to loss of some claudin proteins and
gain of other claudin proteins may allow inappropriate diffu-
sion of paracrine factors, which maymediate the survival and
growth of tumor cells. Our studies define, for the first time, the
pattern of claudin expression and distribution in normal and
tumorigenic mouse ovaries. In this study, we were not able
to determine the hormonal regulation of claudin-1 as the
presently available ID-8 cell line did not express claudin-1.
We speculate that the serial passages [15] used for securing
these tumorigenic cells, albeit from wild-type mice, might
have led to the maximum downregulation of claudin-1 that
could not be altered any further by additional treatments, as
used in this study. Thus, it would be reasonable to pro-
pose that strategies directed at manipulating—in this case
restoring—claudin-1 might prevent tumor cell propagation.
Pituitary gonadotropins, androgens, estrogens, and pro-
gesterone, as well as insulin-like growth factor-1/2, have all
been proposed to influence ovarian tumor development [4].
However, the role played by reproductive hormones on TJs
of the ovary and on tumorigenesis is not known. This study,
using a mouse model, shows that increased androgen in the
absence of FSH-R signaling in vivo results in alterations in
claudin-11 protein expression—a process that may play an
important role in the migration of epithelial cells into the ovary
in the absence of ovulation. Using the only mouse ovarian
surface epithelial cell line available to us, we show that al-
though FSH decreases claudin-11, androgen increases this
protein. Thus, lack of FSH action and increased levels of
androgen in the FORKO ovary are possible mechanisms that
result in a dramatic increase in claudin-11 levels in the ovary.
This is consistent with our recent findings of the presence of
LH and androgen receptors in the normal OSE and their
increase in FORKO mice (unpublished results). Given their
importance in maintaining TJ integrity, which might be critical
for preventing pathological changes and eventual neoplasia,
it would be important to further explore steroidal effects in
regulating the expression of these proteins.
Further evidence that epithelial cells in knockout mice are
altered comes from the fact that there is an increased ex-
pression of E-cadherin and N-cadherin in our FORKOmutant
ovaries (unpublished results). Unlike other epithelial tumors,
E-cadherin (a tumor suppressor) and N-cadherin are over-
expressed in epithelial ovarian tumors, enhancing cell prolif-
eration and survival [33,34]. In summary, we propose that
FSH-R signaling provides a balanced hormonal environment
beneficial for regulating cell–cell interactions that organize
and maintain polarity in surface epithelial cells of the ovary
that exert restraining influence (Figure 7). Based on chrono-
logical evidence gathered from FORKO mice, we suggest
that ovarian hormonal imbalances associated with (gradual)
loss of FSH-R signaling in perimenopause and menopause,
along with other genetic dispositions and environmental
factors, might lead to aberrant expression of claudin family
(and cadherin proteins), allowing inappropriate paracrine/
intracrine influences emanating from other ovarian compart-
ments to enhance cell migration and tumorigenic propensity.
Understanding how events associated with early and al-
tered expressions of selected claudin members and their
signaling functions contribute to ovarian pathology will be
critical. Further efforts to secure altered epithelial cells from
FORKO mutants might accelerate in vitro and in vivo model-
ing studies aimed at understanding mechanistic issues and
devising appropriate strategies aimed at reversal. Finally, our
study confirms previously known claudin gene expression
Figure 7. Schematic representation of hormonal imbalances leading to alterations affecting epithelial cell – cell interactions in the ovary. (A) Normal ovary: the
presence of FSH-R ensures normal cyclicity of hormones and regulation of cell junction status in the OSE. (B) In the FORKO mouse model, the lack of beneficial
effects of FSH-R signaling induces major perturbations in hormones that alter signal transduction pathway(s) and the internal milieu of the ovary, leading to
alterations in OSE in mutants. Although we have not investigated different pathways, signaling through TGF, Wnt, and MAPK, which have been previously shown
to be involved in regulating various cell junctions, is also depicted. Here we implicate that hormonal imbalances result in increases in claudin-3, claudin-4, and
claudin-11, whose effects are transmitted downstream, causing ovarian surface epithelial cells to acquire the capacity to survive and migrate inside the ovary.
Subsequently, serous papillary epithelial adenomas develop in aging FORKO mice.
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patterns in an experimental model and identifies major al-
terations in a new claudin member (claudin-11), which may
have applications in the detection of ovarian cystadenoma.
This work might help stimulate additional studies in exploring
this possibility.
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